Skip to search.
 All Ordinaries Up 0.35%

Neostem, Inc. (NBS)

-NasdaqCM
3.79 Down 0.04(1.05%) 02:18 - Nasdaq Real-Time Price
Add to Portfolio
Prev Close:3.83
Open:3.80
Bid:3.80 x 500
Ask:3.81 x 100
1y Target Est:18.67
Beta:-0.23
Next Earnings Date:N/A
Day's Range:3.78 - 3.84
52wk Range:3.12 - 3,010.00
Volume:54,668
Avg Vol (3m):286,210
Market Cap:135.44M
P/E (ttm):N/A
EPS (ttm):-1.84
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NBSDown 1.05%135.44M
BAXUp 0.29%37.33B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.79
Quarterly EPS Est (Dec-14) :-0.42
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a biotechnology company, develops cell based therapeutics. It is developing a Phase III targeted cancer immunotherapy product to enhance the destruction of cancer initiating cells; a Phase II ischemic repair product candidate to tre... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback